Dyne Therapeutics, Inc. (DYN)
16.56
-0.14
(-0.84%)
USD |
NASDAQ |
Jan 20, 16:00
16.56
0.00 (0.00%)
After-Hours: 16:40
Dyne Therapeutics Shareholders Equity (Quarterly): 691.78M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Avidity Biosciences, Inc. | 1.886B |
| Structure Therapeutics, Inc. | 770.02M |
| MannKind Corp. | -44.55M |
| Sarepta Therapeutics, Inc. | 1.320B |
| Denali Therapeutics, Inc. | 926.20M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 867.06M |
| Total Liabilities (Quarterly) | 175.28M |
| Debt to Equity Ratio | 0.1741 |
| Current Ratio | 13.47 |
| Net Debt Paydown Yield | -1.05% |